The Week Ahead: COS...
Health Care: Drugs
Immunomedics Inc. (IMMU: NASDAQ)
$3.36 0.08 | 2.44%
05/24/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| IMMU | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 33.33 | 0.60 | -1.80 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 122.50 | 0.09 | 0.03 |
| Net Income | -0.64 | -0.29 | |
| EPS | -0.67 | -0.30 |
Earnings for IMMU:
| EBITDA | 874.17K |
| REVENUE | 32.73M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (06/13) | FY (06/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.09 | $n.a. | $-0.38 | $-0.48 |
| Number of Analysts | 1 | 0 | 1 | 1 |
| High Estimate | $-0.09 | $n.a. | $-0.38 | $-0.48 |
| Low Estimate | $-0.09 | $n.a. | $-0.38 | $-0.48 |
| Prior Year | $-0.10 | $-0.10 | $0.01 | $-0.38 |
| Growth Rate (Year over Year) | 10.00% | n.a.% | -3,900.00% | -26.32% |
Portfolios with IMMU
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor5 Stocks to Watch Under $5
- Usertoms
- UserASCO 2010
- UserPortfolioRadical1
- UserPART 7 JPMorgan 28th Annual...
- Userinvestone
- Usermchish Portfolio 1
- UserASCO 2009 Nymph's Watch List.
Latest IMMU Headlines from TheStreet
- Biotech Stock Mailbag: Amarin, MannKind, Palatin 05.24.13 | 07:05 am
- Commit To Purchase Immunomedics At $2, Earn 22.8% Annualized 05.23.13 | 02:05 pm
- 3 Health Care Stocks Under $10 to Watch 05.09.13 | 09:05 pm
- Immunomedics Announces Third Quarter Fiscal 2013 Results And Clinical Program Developments 05.08.13 | 04:05 pm
- Immunomedics Announces Three New Patent Awards 05.07.13 | 08:05 am
- Immunomedics Announces Conference Call And Webcast For Third Quarter Fiscal 2013 Financial Results 04.25.13 | 08:04 am
- Immunomedics Develops T-Cell Redirecting Bispecific Antibodies As Potential Therapeutics For Solid And Liquid Tumors 04.10.13 | 08:04 am
- Immunomedics Reports First Results Of Labetuzumab-SN-38 In Colorectal Cancer 04.09.13 | 08:04 am
- Immunomedics Creates Novel Antibody-Cytokine Conjugates For Cancer Therapy 04.08.13 | 04:04 pm
- Immunomedics Announces Clivatuzumab-Based Blood Test Can Differentiate Between Pancreatic Cancer And Chronic Pancreatitis 04.08.13 | 01:04 pm
Press Releases for IMMU
Partner Headlines for IMMU
- Immunomedics Reports Clinically Meaningful Improvements for Lupus Patients Treated with Epratuzumab - Benzinga 11.13.12 | 09:11 am
- Merck Facing Too Much Competition In HIV Drug Push - Seeking Alpha 08.22.12 | 09:08 am
- CNS Cure Priority for UCB & Partner - Analyst Blog - Zacks 01.13.12 | 10:01 am
- Immunomedics Reports Subcutaneous Injections of Low-Dose Veltuzumab Produced High Rates of Response in Relapsed Immune - Benzinga 12.12.11 | 01:12 pm
- Baker's Dozen Trying To Beat The Odds In Pancreatic Cancer - Seeking Alpha 10.25.11 | 08:10 am
- Immunomedics Reports Advances With New Imaging Agent Developments for Positron Emission Tomography - Benzinga 06.08.11 | 04:06 pm
- UCB's Progress On-Track - Analyst Blog - Zacks 01.12.11 | 09:01 am
- Monoclonal Antibody Companies Command Premiums - Seeking Alpha 07.12.10 | 08:07 am
- Zacks Analyst Blog Highlights: Immunomedics, Human Genome, GlaxoSmithKline, CNOOC and Devon Energy - Press Releases - Zacks 06.22.10 | 09:06 am
- UPDATE 1-Immunomedics says lupus drug shows efficacy - Reuters 06.16.10 | 07:06 am
